Prognostic value of early lymphocyte dynamics during blinatumomab therapy in relapsed or refractory B-cell precursor acute lymphoblastic leukemia: A real-world retrospective study. (PubMed, Ther Adv Hematol) - Sep 11, 2026 - "Early lymphocyte expansion during blinatumomab therapy, reflected by ΔALC14, is an independent predictor of treatment response. ALC monitoring may offer a simple, cost-effective tool for risk stratification."
Journal • Real-world evidence • Retrospective data • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology
|
|
Byung-Sik Cho; Chang-Ki Min; Daehun Kwag; Gi June Min; Hee-Je Kim; Jae-Ho Yoon; Ki-Seong Eom; Seok-Goo Cho; Seonghan Lee; Silvia Park; Sung-Eun Lee; Sung-Soo Park; Yoo-Jin Kim
|